Literature DB >> 33360046

Clusterin: Always protecting. Synthesis, function and potential issues.

Carmen Rodríguez-Rivera1, Miguel M Garcia2, Miguel Molina-Álvarez2, Carmen González-Martín3, Carlos Goicoechea2.   

Abstract

In the last years, clusterin, a challenging and paradoxical apolipoprotein, has been of growing interest amongst a rising number of scientists. This enigmatic protein is present in all fluids of the organism besides within the intracellular matrix, and it plays diverse, and at times contrary, roles in a growing number of pathologies. It seems to vary its location and function to assure cellular survival being cytoprotective hence its significance in neuroprotection and cancer along with chemotherapy resistance. However, it can also lead to cellular arrest and its modulation to apoptosis. Additionally, it has been described to modulate pain, as well as linked to inflammation, cardioprotection, satiety and hunger, and possibly to addictive behaviour development. Thus, it has been postulated to be used both as a biomarker and a very explorable new therapeutic target for several conditions.
Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Biomarkers; Cancer; Cardioprotective agents; Clusterin; Cytoprotection; Drug targeting; Neuroprotection; Pain management

Year:  2020        PMID: 33360046     DOI: 10.1016/j.biopha.2020.111174

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  14 in total

Review 1.  The Perspectives of Biomarkers in Predicting the Survival of the Renal Graft.

Authors:  Paul Luchian Aldea; Andreea Liana Rachisan; Bogdan Ioan Stanciu; Andrei Picos; Alina Monica Picos; Dan Ioan Delean; Ramona Stroescu; Magdalena Iuliana Starcea; Cristina Maria Borzan; Florin Ioan Elec
Journal:  Front Pediatr       Date:  2022-06-03       Impact factor: 3.569

2.  Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.

Authors:  Taejun Yoon; Sung Soo Ahn; Jung Yoon Pyo; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Yonsei Med J       Date:  2021-11       Impact factor: 2.759

Review 3.  Exploring the translational potential of clusterin as a biomarker of early osteoarthritis.

Authors:  Ursule Kalvaityte; Csaba Matta; Eiva Bernotiene; Peter Natesan Pushparaj; Ata M Kiapour; Ali Mobasheri
Journal:  J Orthop Translat       Date:  2021-12-10       Impact factor: 5.191

Review 4.  Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges.

Authors:  Victor E Nava; Pin-Yu Perera; Nirbhay Kumar; Maneesh Jain
Journal:  Vaccines (Basel)       Date:  2022-02-11

5.  Deregulated Clusterin as a Marker of Bone Fragility: New Insights into the Pathophysiology of Osteoporosis.

Authors:  Virginia Veronica Visconti; Chiara Greggi; Ida Cariati; Beatrice Gasperini; Ambra Mastrogregori; Annalisa Botta; Umberto Tarantino
Journal:  Genes (Basel)       Date:  2022-04-07       Impact factor: 4.141

Review 6.  Transcript-Targeted Therapy Based on RNA Interference and Antisense Oligonucleotides: Current Applications and Novel Molecular Targets.

Authors:  Vincenza Barresi; Camillo Musmeci; Alessandro Rinaldi; Daniele Filippo Condorelli
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

7.  Clusterin and Its Potential Regulatory microRNAs as a Part of Secretome for the Diagnosis of Abnormally Invasive Placenta: Accreta, Increta, and Percreta Cases.

Authors:  Angelika V Timofeeva; Ivan S Fedorov; Mariya M Pirogova; Oksana N Vasilchenko; Vitaliy V Chagovets; Larisa S Ezhova; Tatiana M Zabelina; Roman G Shmakov; Gennadiy T Sukhikh
Journal:  Life (Basel)       Date:  2021-03-24

8.  Dynamic Changes in Central and Peripheral Neuro-Injury vs. Neuroprotective Serum Markers in COVID-19 Are Modulated by Different Types of Anti-Viral Treatments but Do Not Affect the Incidence of Late and Early Strokes.

Authors:  Krzysztof Laudanski; Jihane Hajj; Mariana Restrepo; Kumal Siddiq; Tony Okeke; Daniel J Rader
Journal:  Biomedicines       Date:  2021-11-29

Review 9.  HDL Accessory Proteins in Parkinson's Disease-Focusing on Clusterin (Apolipoprotein J) in Regard to Its Involvement in Pathology and Diagnostics-A Review.

Authors:  Izabela Berdowska; Małgorzata Matusiewicz; Małgorzata Krzystek-Korpacka
Journal:  Antioxidants (Basel)       Date:  2022-03-09

Review 10.  Altered protein secretion in Batten disease.

Authors:  Robert J Huber
Journal:  Dis Model Mech       Date:  2021-12-06       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.